HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-glomerular basement membrane disease after alemtuzumab.

AuthorsMenna R Clatworthy, Elizabeth F Wallin, David R Jayne
JournalThe New England journal of medicine (N Engl J Med) Vol. 359 Issue 7 Pg. 768-9 (Aug 14 2008) ISSN: 1533-4406 [Electronic] United States
PMID18703487 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab
Topics
  • Acute Kidney Injury (chemically induced)
  • Adult
  • Alemtuzumab
  • Anti-Glomerular Basement Membrane Disease (chemically induced)
  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Monoclonal (adverse effects)
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm (adverse effects)
  • Antineoplastic Agents (adverse effects)
  • Female
  • Humans
  • Male
  • Multiple Sclerosis, Relapsing-Remitting (drug therapy)
  • Vasculitis (drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: